Stereotactic Radiosurgery
Stereotactic Radiosurgery is a radiation therapy with 131 clinical trials. Currently 40 active trials ongoing. Historical success rate of 70.1%.
Success Metrics
Based on 47 completed trials
Phase Distribution
Phase Distribution
37
Early Stage
37
Mid Stage
22
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
59.5%
47 of 79 finished
40.5%
32 ended early
40
trials recruiting
131
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Pembrolizumab In Central Nervous System Metastases
Clinical Trials (131)
Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Pembrolizumab In Central Nervous System Metastases
Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Neurocognitive Decline in Patients With Brain Metastases
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 131